Harvard Bioscience (HBIO) Total Current Liabilities (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Total Current Liabilities of $23.9 million for Q1 2026, down 57.08% year-over-year from $55.6 million in Q1 2025, and up 8.67% quarter-over-quarter from $22.0 million in Q4 2025.
Harvard Bioscience (HBIO) Total Current Liabilities (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Total Current Liabilities for 17 consecutive years, with $23.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 57.08% year-over-year to $23.9 million; the TTM figure through Mar 2026 stood at $23.9 million (down 57.08% YoY), while the FY2025 annual figure was $22.0 million, down 60.04% from the prior year.
- Total Current Liabilities rose to $23.9 million in Q1 2026 per HBIO's latest filing, from $22.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $55.6 million in Q1 2025 and bottomed at $21.4 million in Q3 2022.
- Historically, Total Current Liabilities has averaged $31.1 million across 5 years, with a median of $23.9 million in 2026.
- On a YoY basis, Total Current Liabilities climbed as much as 144.03% in 2025 and fell as far as 60.04% in 2025.
- Harvard Bioscience's Total Current Liabilities stood at $23.2 million in 2022, then increased by 14.16% to $26.5 million in 2023, then surged by 107.06% to $55.0 million in 2024, then slumped by 60.04% to $22.0 million in 2025, then rose by 8.67% to $23.9 million in 2026.
- Business Quant data shows HBIO's Total Current Liabilities at $23.9 million in Q1 2026, $22.0 million in Q4 2025, and $54.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn | 24.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.79 Mn |
| Mar 31, 2026 | 23.86 Mn |
| Dec 31, 2025 | 21.96 Mn |
| Sep 30, 2025 | 54.40 Mn |
| Jun 30, 2025 | 55.20 Mn |
| Mar 31, 2025 | 55.60 Mn |
| Dec 31, 2024 | 54.96 Mn |
| Sep 30, 2024 | 22.75 Mn |
| Jun 30, 2024 | 22.62 Mn |
| Mar 31, 2024 | 25.68 Mn |
| Dec 31, 2023 | 26.54 Mn |
| Sep 30, 2023 | 24.21 Mn |
| Jun 30, 2023 | 22.94 Mn |
| Mar 31, 2023 | 23.22 Mn |
| Dec 31, 2022 | 23.25 Mn |
| Sep 30, 2022 | 21.36 Mn |
| Jun 30, 2022 | 23.35 Mn |
| Mar 31, 2022 | 27.23 Mn |
| Dec 31, 2021 | 25.32 Mn |
| Sep 30, 2021 | 23.51 Mn |